Kan I, Melamed E, Offen D
Felsenstein Medical Research Center, Department of Neurology, Rabin Medical Center-Beilinson Campus, Petach Tikva, The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Curr Drug Targets. 2005 Feb;6(1):31-41. doi: 10.2174/1389450053344902.
Bone marrow derived mesenchymal stem cells (MSC) are adult stem cells that reside within the bone marrow compartment. In the traditional developmental model, adult stem cells are able to differentiate only to the tissue in which they reside. Recent data have challenged the committed fate of the adult stem cells, presenting evidence for their multi-lineage differentiation potential. In addition, potential therapeutic benefits of MSC administration have been the main concern of much research, including clinical trials. These studies promote adult stem cell therapy by shedding some light on the therapeutic potential of MSC and their mechanism of action. Many doubts have found their way into MSC research. They question MSC potency and beneficial contribution. However, these obstacles should not arrest but set a challenge to MSC researchers to examine their achievements under a magnifying glass. Therapeutic benefits of MSC exogenous delivery do not run counter to its possible participation in endogenous repair. Several reports imply MSC involvement in physiological repair but no explicit data support this hypothesis. This review tries to put MSC research into perspective. Possible therapeutic applications of MSC therapy for damaged tissue replacement, tissue engineering and the underlying repair mechanisms will be discussed. In addition, reported data about MSC possible involvement in physiological multiple tissue repair, their homing to injury and site-specific differentiation will be presented.
骨髓间充质干细胞(MSC)是存在于骨髓腔室中的成体干细胞。在传统的发育模型中,成体干细胞仅能分化为它们所在的组织。最近的数据对成体干细胞的既定命运提出了挑战,提供了它们具有多谱系分化潜能的证据。此外,施用MSC的潜在治疗益处一直是包括临床试验在内的许多研究的主要关注点。这些研究通过揭示MSC的治疗潜力及其作用机制,推动了成体干细胞治疗。许多疑问已进入MSC研究领域。它们质疑MSC的效力和有益贡献。然而,这些障碍不应阻碍MSC研究人员,反而为他们提出了一项挑战,即要仔细审视自己的研究成果。MSC外源性递送的治疗益处与其可能参与内源性修复并不矛盾。一些报告暗示MSC参与生理修复,但没有明确的数据支持这一假设。本综述试图全面看待MSC研究。将讨论MSC治疗在受损组织替代、组织工程方面可能的治疗应用以及潜在的修复机制。此外,还将介绍有关MSC可能参与生理性多组织修复、它们归巢至损伤部位以及位点特异性分化的报道数据。